Switzerland : DKSH and DFE Pharma sign exclusive distribution agreement for eight European countries.
DKSH s Business Unit Performance Materials, a leading specialty chemicals distributor, has been appointed exclusive Market Expansion Services partner for DFE Pharma s Pharmacel MCC excipient for France, Switzerland, UK, Ireland, Denmark, Finland, Norway and Sweden.
DFE Pharma is the global leader in excipient solutions and develops, produces and markets excipients for oral solid dose and dry powder inhalation formulations.
DKSH presently partners DFE Pharma in the Philippines, where DKSH provides Market Expansion Services to DFE Pharma s starch and disintegrants product range. DFE Pharma expands its collaboration with DKSH for its first-class reputation in providing integrated and tailored Market Expansion Services along the entire value chain, as well as for its comprehensive network and strong customer base in Europe.
We are very pleased that DFE Pharma has chosen DKSH once again as their Market Expansion Services partner for the distribution of their Pharmacel MCC excipient. Thanks to our unmatched footprint in Europe, we can leverage on our size, experience and industry know-how to provide tailored services and exceptional distribution opportunities for DFE Pharma, said Tanja Schaffer, Vice President Pharmaceutical Industry, DKSH Performance Materials.
The agreement will further strengthen DKSH s market position in the regions while contributing to the Group s overall profitability over time.
2015 Al Bawaba (Albawaba.com) Provided by SyndiGate Media Inc. ( Syndigate.info ).
|Printer friendly Cite/link Email Feedback|
|Date:||Mar 4, 2015|
|Previous Article:||Switzerland : Lexus LF-SA Concept Debuts at Geneva Motorshow.|
|Next Article:||Switzerland : All-New Tucson leads youngest European Hyundai Motor line-up at 2015 Geneva Motor Show.|